Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA advisory committee will meet to discuss Avakine NDA

April 28, 1998

Roberts acquires Pentasa marketing rights from HMR

April 27, 1998

Lamivudine consistently effective as a treatment for hepatitis B

April 27, 1998

New prokinetic agent emerges from the pipeline at Zeria

April 24, 1998

Novel flavone and flavanone compounds for ulcers, IBD

April 24, 1998

New trypsin inhibitor with potential in treating pancreatitis

April 23, 1998

Chugai synthesizes prokinetic erythromycins

April 23, 1998

Potent and selective anti-H. pylori agents in the pipeline at Zenyaku Kogyo

April 23, 1998

New beta3-agonist presented by Tokyo Tanabe

April 22, 1998

Veldona to be marketed in Ghana

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...